Results 151 to 160 of about 20,646 (210)

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer. [PDF]

Breast Cancer Res
de Gruil N, de Groot AF, Wesseling-Rozendaal Y, Keizer D, Koekenbier CS, Vermeer S, Cohen D, Heijns JB, Mandigers CMPW, van de Wouw AJ, Cloos-van Balen M, Ropela JA, Oosterkamp HM, van Bekkum ML, Houtsma D, Biezen ED, Liefers GJ, Linn SC, Kroep JR.   +18 more
europepmc   +1 more source

Phenotype-specific efficacy of letrozole versus clomiphene citrate in polycystic ovary syndrome: a prospective cohort study. [PDF]

BMC Womens Health
Aytemiz EA, Aslan B, Kaplan NB, Aytaç R, Atabekoğlu C, Berker B, Sönmezer M, Özmen B, Şükür YE.   +8 more
europepmc   +1 more source

Long-term control for > 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report. [PDF]

Front Oncol
Liu L, Ma L, Yang L, He W.
europepmc   +1 more source

Aromatase inhibitors induce pain-like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization. [PDF]

Br J Pharmacol
Caillaud M, Herz SM, Koseli E, Roberts J, Ulker E, Jessup D, McKiver B, Silva GM, Betancourt-Toscano I, Diaz NJ, Khan A, Poklis JL, Henry NL, Akbarali H, Damaj MI.   +14 more
europepmc   +1 more source

MeCP2 Governs maternal hyperandrogenism-induced cortical defects and behavioral alterations via noncanonical AR-dependent regulation of Mef2c. [PDF]

Nat Commun
Wang YM, Jia Y, Wu Y, Zhao Q, Guo Y, Zhang L, Jin M, Zheng Y.   +7 more
europepmc   +1 more source

Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial. [PDF]

Clin Cancer Res
Bianchini G, Malorni L, Caputo R, Zambelli A, Puglisi F, Bianchi GV, Del Mastro L, Paris I, Montemurro F, Colleoni M, Allegrini G, Tamberi S, Zamagni C, Cazzaniga ME, Orditura M, Guarneri V, Adamo V, Romagnoli E, Valerio MR, Cinieri S, Benelli M, Callari M, Valsecchi D, Castelletti D, Grasso D, Fenderico N, Arpino G, De Laurentiis M.   +27 more
europepmc   +1 more source

Letrozole Reduces Ovulatory Responsiveness in In Vitro-Grown Mouse Follicles. [PDF]

Reprod Med Biol
Kobayashi T, Ishikawa H, Tanaka H, Ishii K, Mitsuhashi A, Usui H, Shozu M, Koga K.   +7 more
europepmc   +1 more source

Missingness in Eligibility Criteria for Target Trial Emulation in EHR With Survival Outcomes. [PDF]

Stat Med
Shen J, Linn KA, Clark AS, Mamtani R, Hubbard RA.   +4 more
europepmc   +1 more source

Retraction Note: Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial. [PDF]

Arch Gynecol Obstet
Ibrahim MI, Moustafa RA, Abdel-Azeem AA.
europepmc   +1 more source

Efficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies. [PDF]

Oncol Res
Patwekar M, Patwekar F, Kari ZA, Zain MRAM, Mohammed A, Sharma R.   +5 more
europepmc   +1 more source